Items with tag "drug discovery"

News

Medulloblastoma orphan drug designation for Oncurious

Oncurious, an emerging oncology company focused on the development of innovative orphan drugs for the treatment of pediatric tumors, announces that the European Commission has confirmed the orphan…

Read more

John Berriman heads the Confo Therapeutics board

GPCR drug designer Confo Therapeutics has announced that John Berriman was appointed as Chairman of the Board. Berriman is a known biotech veteran and has served on the boards of many biotech comp…

Read more

Insights

How CRISPR/Cas9 is improving drug development using zebrafish

How CRISPR/Cas9 is improving drug development using zebrafish

CRISPR/Cas9 came to the attention of scientists everywhere over five years ago. Ever since it hit the main stage, the gene editing technique has stayed in the spotlight, and for good reason. CRISP…

Read more

Galapagos and MorphoSys to receive up to EUR 850mil in deal with Novartis

Galapagos and MorphoSys to receive up to EUR 850mil in deal with Novartis

Galapagos (Belgium) and MorphoSys (Germany) recently announced that they have entered into an exclusive global license agreement with Novartis. The Swiss big-pharma partner has acquired the rights…

Read more

A world without disease: Janssen - Flanders.bio partner day 2018

A world without disease: Janssen - Flanders.bio partner day 2018

A new vision was in the spotlight at the Flanders.bio - Janssen Pharmaceutica Partner Day this year. “A world without disease” was the slogan on everyone’s tongues as Janssen’s representatives and…

Read more

Fishing for answers: screening drug cardiotoxicity using zebrafish

Fishing for answers: screening drug cardiotoxicity using zebrafish

Rodents have a well-established place in history as our most common animal models. Even the word lab-rat has become so commonplace it is a common lay-man term. However, could it be that another an…

Read more

UCB psoriasis drug approved for use in mothers

UCB psoriasis drug approved for use in mothers

The UCB core drug CIMZIA® has just been approved by European Medicines Agency (EMA) for use in pregnant and breastfeeding mothers. The company has also sought to have CIMZIA approved for psoriasis…

Read more

WHO report ranks deadly diseases in need of drugs

WHO report ranks deadly diseases in need of drugs

The World Health Organization recently released a report outlining the imminent threat of antimicrobial-resistant diseases. In the midst of such doom and gloom, could a solution be found in our ow…

Read more

The Cystic Fibrosis association pushes research to the next level

The Cystic Fibrosis association pushes research to the next level

Cystic fibrosis (CF) is a life-threatening disease, for which there is currently no treatment. There are some drugs on the market that, in certain cases, can alleviate the symptoms. In this articl…

Read more

AI improves patient care

AI improves patient care

Curing and caring for patients is a comprehensive process that requires research to discover new drugs, clinical trials to test the safety and efficacy of those drugs, and coaching and mentoring t…

Read more

Animal venom: a pharmacological goldmine

Animal venom: a pharmacological goldmine

Until recently, not many people had heard of Alphabiotoxine—a rapidly developing Belgian company and the largest producer of diverse animal venoms in the world. All venoms hold a mixture of hundre…

Read more

VC Views

Bringing clinical trials into the home

Bringing clinical trials into the home

Lowering the costs of drug development is more important than ever; with the increasing pressure on drug pricing and billions in funding poured into small biotechs, competition is fierce. While th…

Read more

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

Itera Life Science Janssen UGent KU Leuven Biowin Turnstone Flanders.bio GSK V-Bio Ventures XpandInnovation

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.